Butyric acid enhances in vivo expression of hTNF-α in transduced melanoma cell line

Anticancer Research

Volumn 21, Issue 6 A, 2001, Pages 4001-4004

  Giermasz, Adam ^a   Grzela, Tomasz ^a   Nowis, Dominika ^a   Makowski, Marcin ^a   Czajka, Anna ^a   Stoklosa, Tomasz ^a   Lasek, Witold ^a   Dabrowska, Anna ^a   Wiznerowicz, Maciej ^a   Mackiewicz, Andrzej ^a   Jakóbisiak, Marek ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Cancer; Retroviral vector; Sodium butyrate; TNF ; Tributyrin; Vaccine

Indexed keywords

BUTYRIC ACID; CANCER VACCINE; COMPLEMENTARY DNA; PLASMID DNA; RETROVIRUS VECTOR; TRIBUTYRIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL GROWTH; GENE EXPRESSION; GENE THERAPY; GROWTH RATE; MELANOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VACCINATION;

ANIMALS; BUTYRATES; CELL DIVISION; HUMANS; MELANOMA, EXPERIMENTAL; MICE; RETROVIRIDAE; TRANSDUCTION, GENETIC; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035570832     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Short chain fatty acids in the human colon
2. Butyrate-induced G2/M block in Caco-2 Colon Cancer Cells is associated with decreased p34cdc2 activity
3. Butyrate-induced G1 arrest results from p21-independent disruption of retinoblastoma protein-mediated signals
4. Butyrate stimulates cyclin D and p21 and inhibits cyclin-dependent kinase 2 expression in HT-29 colonic epithelial cells
5. Sodium butyrate induces G2 arrest in the human breast cancer cells MDA-MB-231 and renders them competent for DNA rereplication
6. p21(WAF1) is required for butyrate-mediated growth inhibition of human colon cancer cells
7. Carboxypeptidase A3 (CPA3): A novel gene highly induced by histone deacetylase inhibitors during differentiation of prostate epithelial cancer cells
8. Histone deacetylase inhibitors as potential anti-skin cancer agents
9. Initiation of growth arrest and apoptosis of MCF-7 mammary carcinoma cells by tributyrin, a triglyceride analogue of the short-chain fatty acid butyrate, is associated with mitochondrial activity
10. Sodium butyrate induces apoptosis in human colonic tumour cell lines in a p53-independent pathway: Implications for the possible role of dietary fibre in the prevention of large-bowel cancer
11. Butyric acid and pivaloyloxymethyl butyrate, AN-9, a novel butyric acid derivative, induce apoptosis in HL-60 cells
12. The effect of butyric acid and retinoic acid on invasion and experimental metastasis of murine melanoma cells
13. An interleukin 2/sodium butyrate combination as immunotherapy for rat colon cancer peritoneal carcinomatosis
14. Differentiative and proliferative effects of (But)2cAMP, n-butyric acid and prednisolone on the malignant melanoma cell line (TM-1) in vitro and in vivo
15. Growth inhibition of murine melanoma by butyric acid and dimethylsulfoxide
16. Antitumor activity of tributyrin in murine melanoma model
17. Phase I study of the orally administered butyrate prodrug, tributyrin, in patients with solid tumors
18. Phase I trial of interleukin-2 and high-dose arginine butyrate in metastatic colorectal cancer
19. Sodium butyrate inhibits histone deacetylation in cultured cells
20. Expression and up-regulation of interleukin-6 in oesophageal carcinoma cells by n-sodium butyrate
21. Butyrate regulates E-cadherin transcription, isoform expression and intracellular position in colon cancer cells
22. Effect of sodium butyrate on the expression of genes transduced by retroviral vectors
23. Antigen-specific tumor vaccines. Development and characterization of recombinant adenoviruses encoding MART1 or gp100 for cancer therapy
24. Transient and stable gene expression in mammalian cells transduced with a recombinant baculovirus vector
25. Cytokine gene therapy: Hopes and pitfalls
26. Gene therapy for cancer: What have we done and where are we going?
27. Antitumor effects of the combination therapy with TNF-α gene modified tumor cells and interleukin-12 in melanoma model in mice
28. Tumor suppression after tumor cell-targeted tumor necrosis factor alpha gene transfer
29. Mechanisms of rejection induced by tumor cell-targeted gene transfer of interleukin 2, interleukin 4, interleukin 7, tumor necrosis factor, or interferon gamma
30. Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with interleukin (IL)-2, IL-4, IL-6, IL-7, IL-10, tumor necrosis factor alpha, granulocyte-macrophage colony-stimulating factor, and gamma-interferon gene or admixed with conventional adjuvants
31. Potentiation of antitumor effect of tumor necrosis factor α and interferon γ by macrophage colony-stimulating factor in a MmB16 melanoma model in mice
32. Differential spontaneous expression of mRNA for IL-4, IL-10, IL-13, IL-2 and interferon-gamma (IFN-gamma) in peripheral blood mononuclear cells (PBMC) from atopic patients
33. OKT3-induced cytokine mRNA expression in human peripheral blood mononuclear cells measured by polymerase chain reaction
34. Effect of allergen immunotherapy on interleukin-4 and interferon-γ production by peripherial blood mononuclear cells of grass pollen-sensitive atopic children